Cancer stem cells and markers: New model of tumorigenesis with therapeutic implications

Cancer Biomarkers

Volumn 9, Issue 1-6, 2011, Pages 65-99

  Natarajan, Thanemozhi G ^a,b   Ganesan, Natarajan ^a   Fitzgerald, Kevin T ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

asymmetric division; Cancer; canonical pathways; clinical implications; communication; detoxifying proteins; immortality; markers; signaling pathways; stem cell niche; stem cells; stemness; surface antigens; transcription factors

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN TIE2; ANTINEOPLASTIC AGENT; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CELL MARKER; CX CHEMOKINE LIGAND; GAMMA SECRETASE INHIBITOR; MEMBRANE ANTIGEN; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN; SONIC HEDGEHOG PROTEIN; STEM CELL FACTOR; TELOMERASE; TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM SIGNALING; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL DIVISION; CELL HOMING; CELL INTERACTION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE MARKER; DNA DAMAGE; DNA STRAND; ENZYME ACTIVITY; EPIGENETICS; GENE DISRUPTION; GENE POOL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; LUNG CANCER; MEDULLOBLASTOMA; MELANOMA; MOLECULARLY TARGETED THERAPY; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHENOTYPE; PRIMED IN SITU LABELING; PRIORITY JOURNAL; PROSTATE CANCER; RETINOBLASTOMA; SARCOMA; STEM CELL NICHE; SURVIVAL RATE; TISSUE REGENERATION;

ANIMALS; BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 82955193351     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0173     Document Type: Article

References (395)

1. M. Al Hajj and M. F. Clarke, Self-renewal and solid tumor stem cells, Oncogene 23 (2004), 7274-7282.
2. I. L. Weissman, D. J. Anderson and F. Gage, Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations 1, Annu Rev Cell Dev Biol 17 (2001), 387-403.
3. P. J. Gokhale and P. W. Andrews, A prospective on stem cell research, Semin Reprod Med 24 (2006), 289-297.
4. S. He, D. Nakada and S. J. Morrison,Mechanisms of stem cell self-renewal, Annu Rev Cell Dev Biol 25 (2009), 377-406.
5. D. G. Tang, L. Patrawala, T. Calhoun, B. Bhatia, G. Choy, R. Schneider-Broussard and C. Jeter, Prostate cancer stem/progenitor cells: identification, characterization, and implications, Mol Carcinog 46 (2007), 1-14.
6. H. Clevers, Stem cells, asymmetric division and cancer, Nat Genet 37 (2005), 1027-1028.
7. L. Rambhatla, S. Ram-Mohan, J. J. Cheng and J. L. Sherley, Immortal DNA strand cosegregation requires p53/IMPDHdependent asymmetric self-renewal associated with adult stem cells, Cancer Res 65 (2005), 3155-3161.
8. M. S. Wicha, S. Liu and G. Dontu, Cancer stem cells: an old idea - a paradigm shift, Cancer Res 66 (2006), 1883-1890.
9. E. Caussinus and C. Gonzalez, Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster, Nat Genet 37 (2005), 1125-1129.
10. G. Q. Daley, Stem cells: roadmap to the clinic, J Clin Invest 120 (2010), 8-10.
11. J. Cai, M. L. Weiss and M. S. Rao, In search of "stemness", Exp Hematol 32 (2004), 585-598.
12. K. Takahashi and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell 126 (2006), 663-676.
13. J. Voog and D. L. Jones, Stem cells and the niche: a dynamic duo, Cell Stem Cell 6 (2010), 103-115.
14. J. Zhang, C. Niu, L. Ye, H. Huang, X. He,W. G. Tong, J. Ross, J. Haug, T. Johnson, J. Q. Feng, S. Harris, L. M. Wiedemann, Y. Mishina and L. Li, Identification of the haematopoietic stem cell niche and control of the niche size, Nature 425 (2003), 836-841.
15. H. Jiang, P. H. Patel, A. Kohlmaier, M. O. Grenley, D. G. McEwen and B. A. Edgar, Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut, Cell 137 (2009), 1343-1355.
16. J. Cheng, N. Turkel, N. Hemati, M. T. Fuller, A. J. Hunt and Y. M. Yamashita, Centrosome misorientation reduces stem cell division during ageing, Nature 456 (2008), 599-604.
17. X. R. Sheng, C. M. Brawley and E. L. Matunis, Dedifferentiating spermatogonia outcompete somatic stem cells for niche occupancy in the Drosophila testis, Cell Stem Cell 5 (2009), 191-203.
18. Y. M. Yamashita, A. P. Mahowald, J. R. Perlin andM. T. Fuller, Asymmetric inheritance of mother versus daughter centrosome in stem cell division, Science 315 (2007), 518-521.
19. T. Nakagawa, Y. Nabeshima and S. Yoshida, Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis, Dev. Cell 12 (2007), 195-206.
20. C. Ramirez-Castillejo, F. Sanchez-Sanchez, C. Andreu- Agullo, S. R. Ferron, J. D. Aroca-Aguilar, P. Sanchez, H. Mira, J. Escribano and I. Farinas, Pigment epithelium-derived factor is a niche signal for neural stem cell renewal, Nat Neurosci 9 (2006), 331-339.
21. C. Calabrese, H. Poppleton, M. Kocak, T. L. Hogg, C. Fuller, B. Hamner, E. Y. Oh, M. W. Gaber, D. Finklestein, M. Allen, A. Frank, I. T. Bayazitov, S. S. Zakharenko, A. Gajjar, A. Davidoff and R. J. Gilbertson, A perivascular niche for brain tumor stem cells, Cancer Cell 11 (2007), 69-82.
22. H. Iwasaki and T. Suda, Cancer stem cells and their niche, Cancer Sci 100 (2009), 1166-1172.
23. Q. Shen, Y. Wang, E. Kokovay, G. Lin, S. M. Chuang, S. K. Goderie, B. Roysam and S. Temple, Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions, Cell Stem Cell 3 (2008), 289-300.
24. F. Arai, A. Hirao, M. Ohmura, H. Sato, S. Matsuoka, K. Takubo, K. Ito, G. Y. Koh and T. Suda, Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche, Cell 118 (2004), 149-161.
25. K. Parmar, P. Mauch, J. A. Vergilio, R. Sackstein and J. D. Down, Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia, Proc Natl Acad Sci U S A 104 (2007), 5431-5436.
26. B. Heissig, K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. Moore, Z. Werb and S. Rafii, Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand 1, Cell 109 (2002), 625-637.
27. G. B. Adams, K. T. Chabner, I. R. Alley, D. P. Olson, Z. M. Szczepiorkowski, M. C. Poznansky, C. H. Kos, M. R. Pollak, E. M. Brown and D. T. Scadden, Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor 1, Nature 439 (2006), 599-603.
28. S. W. Lane, D. T. Scadden and D. G. Gilliland, The leukemic stem cell niche: current concepts and therapeutic opportunities, Blood 114 (2009), 1150-1157.
29. D. T. Scadden, The stem-cell niche as an entity of action, Nature 441 (2006), 1075-1079.
30. S. J. Morrison and A. C. Spradling, Stem cells and niches: mechanisms that promote stem cell maintenance throughout life, Cell 132 (2008), 598-611.
31. E. Fuchs, T. Tumbar and G. Guasch, Socializing with the neighbors: stem cells and their niche 1, Cell 116 (2004), 769-778.
32. K. Raymond, M. A. Deugnier, M. M. Faraldo and M. A. Glukhova, Adhesion within the stem cell niches, Curr Opin Cell Biol 21 (2009), 623-629.
33. C. D. Hillyer and S. J. Wells, Alternative sources of hematopoietic stem cells for bone marrow transplantation and rescue, J. Hematother 2 (1993), 491-499.
34. H. E. Broxmeyer, G. W. Douglas, G. Hangoc, S. Cooper, J. Bard, D. English, M. Arny, L. Thomas and E. A. Boyse, Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells, Proc Natl Acad Sci U S A 86 (1989), 3828-3832.
35. R. P. Gale, Fetal liver transplants, Bone Marrow Transplant 9(Suppl 11992), 118-120.
36. J. E. Dick, Stem cell concepts renew cancer research, Blood 112 (2008), 4793-4807.
37. M. F. Clarke, J. E. Dick, P. B. Dirks, C. J. Eaves, C. H. Jamieson, D. L. Jones, J. Visvader, I. L. Weissman and G. M. Wahl, Cancer stem cells - perspectives on current status and future directions: AACRWorkshop on cancer stem cells, Cancer Res 66 (2006), 9339-9344.
38. D. Bonnet and J. E. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med 3 (1997), 730-737.
39. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M. A. Caligiuri and J. E. Dick, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature 367 (1994), 645-648.
40. M. AlHajj,M. S. Wicha, A. Benito-Hernandez, S. J. Morrison and M. F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci U S A 100 (2003), 3983-3988.
41. M. Al Hajj, M. W. Becker, M. Wicha, I. Weissman and M. F. Clarke, Therapeutic implications of cancer stem cells, Curr Opin Genet Dev 14 (2004), 43-47.
42. T. Reya, S. J. Morrison, M. F. Clarke and I. L. Weissman, Stem cells, cancer, and cancer stem cells, Nature 414 (2001), 105-111.
43. N. Y. Frank, T. Schatton and M. H. Frank, The therapeutic promise of th cancer stem cell concept, J Clin Invest 120 (2010), 41-50.
44. K. A. Kesler, K. M. Rieger, K. N. Ganjoo, M. Sharma, N. S. Fineberg, L. H. Einhorn and J. W. Brown, Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery 1, J Thorac Cardiovasc Surg 118 (1999), 692-700.
45. S. K. Singh, I. D. Clarke,M. Terasaki, V. E. Bonn, C. Hawkins, J. Squire and P. B. Dirks, Identification of a cancer stem cell in human brain tumors 1, Cancer Res 63 (2003), 5821-5828.
46. C. Hemmings, The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis, Pathology 42 (2010), 105-112.
47. I. H. Park, R. Zhao, J. A. West, A. Yabuuchi, H. Huo, T. A. Ince, P. H. Lerou, M. W. Lensch and G. Q. Daley, Reprogramming of human somatic cells to pluripotency with defined factors, Nature 451 (2008), 141-146.
48. N. Maherali, R. Sridharan, W. Xie, J. Utikal, S. Eminli, K. Arnold, M. Stadtfeld, R. Yachechko, J. Tchieu, R. Jaenisch, K. Plath and K. Hochedlinger, Directly reprogrammed fibroblast show global epigenetic remodeling and widespread tissue contribution, Cell Stem Cell 1 (2007), 55-70.
49. F. C. Kelleher, D. Fennelly and M. Rafferty, Common critical pathways in embryogenesis and cancer, Acta Oncol 45 (2006), 375-388.
50. A. P. Feinberg, Phenotypic plasticity and the epigenetics of human disease, Nature 447 (2007), 433-440
51. C. Odoux, H. Fohrer, T. Hoppo, L. Guzik, D. B. Stolz, D. W. Lewis, S. M. Gollin, T. C. Gamblin, D. A. Geller and E. Lagasse, A stochastic model for cancer stem cell origin in metastatic colon cancer, Cancer Res 68 (2008), 6932-6941.
52. J. M. Heddleston, Z. Li, J. D. Lathia, S. Bao, A. B. Hjelmeland and J. N. Rich, Hypoxia inducible factors in cancer stem cells, Br J Cancer 102 (2010), 789-795.
53. L. A. Mathews, F. Crea andW. L. Farrar, Epigenetic gene regulation in stem cells and correlation to cancer, Differentiation 78 (2009), 1-17.
54. L. Jin, K. J. Hope, Q. Zhai, F. Smadja-Joffe and J. E. Dick, Targeting of CD44 eradicates human acute myeloid leukemic stem cells, Nat Med 12 (2006), 1167-1174.
55. S. T. Henderson, D. Gao, E. J. Lambie and J. Kimble, lag- 2 may encode a signaling ligand for the GLP-1 and LIN- 12 receptors of C. elegans, Development 120 (1994), 2913-2924.
56. J. B. Sneddon, H. H. Zhen, K. Montgomery, R. M. van de, A. D. Tward, R. West, H. Gladstone, H. Y. Chang, G. S. Morganroth, A. E. Oro and P. O. Brown, Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation, Proc Natl Acad Sci U S A 103 (2006), 14842-14847.
57. J. Wels, R. N. Kaplan, S. Rafii and D. Lyden, Migratory neighbors and distant invaders: tumor-associated niche cells, Genes Dev 22 (2008), 559-574.
58. A. Colmone,M. Amorim, A. L. Pontier, S. Wang, E. Jablonski and D. A. Sipkins, Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells, Science 322 (2008), 1861-1865.
59. S. Hiratsuka, K. Nakamura, S. Iwai,M. Murakami, T. Itoh, H. Kijima, J. M. Shipley, R. M. Senior and M. Shibuya, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell 2 (2002), 289-300.
60. C. Boccaccio, G. Sabatino, E. Medico, F. Girolami, A. Follenzi, G. Reato, A. Sottile, L. Naldini and P. M. Comoglio, TheMET oncogene drives a genetic programme linking cancer to haemostasis, Nature 434 (2005), 396-400.
61. R. N. Kaplan, R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, Z. Zhu, D. Hicklin, Y. Wu, J. L. Port, N. Altorki, E. R. Port, D. Ruggero, S. V. Shmelkov, K. K. Jensen, S. Rafii and D. Lyden, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature 438 (2005), 820-827.
62. Z. J. Yang and R. J. Wechsler-Reya, Hit 'em where they live: targeting the cancer stem cell niche, Cancer Cell 11 (2007), 3-5.
63. K. D. Bunting, ABC transporters as phenotypic markers and functional regulators of stem cells, Stem Cells 20 (2002), 11-20.
64. A. Rizo, E. Vellenga, H. G. de and J. J. Schuringa, Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? 1, Hum Mol Genet 15(Spec No 22006), R210-R219.
65. C. S. Potten, G. Owen and D. Booth, Intestinal stem cells protect their genome by selective segregation of template DNA strands, J Cell Sci 115 (2002), 2381-2388.
66. G. H. Smith, Label-retaining epithelial cells in mouse mammary gland divide asmetrically and retain their template DNA strands, Development 132 (2005), 681-687.
67. C. S. Potten and R. J. Morris, Epithelial stem cells in vivo, J Cell Sci Suppl 10 (1988), 45-62.
68. C. S. Potten and M. Loeffler, Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt, Development 110 (1990), 1001-1020.
69. R. B. Clarke, E. Anderson, A. Howell and C. S. Potten, Regulation of human breast epithelial stem cells, Cell Prolif 36(Suppl 12003), 45-58.
70. B. Lu, L. Jan and Y. N. Jan, Control of cell divisions in the nervous system: symmetry and asymmetry 1, Annu Rev Neurosci 23 (2000), 531-556.
71. C. Mantel and H. E. Broxmeyer, A new connection between the spindle checkpoint, asymmetric cell division and cytokine signaling 1, Cell Cycle 6 (2007), 144-146.
72. S. J. Morrison and J. Kimble, Asymmetric and symmetric stem-cell divisions in development and cancer 1, Nature 441 (2006), 1068-1074.
73. R. Zhang, Z. Zhang, C. Zhang, L. Zhang, A. Robin, Y. Wang, M. Lu and M. Chopp, Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat, J Neurosci 24 (2004), 5810-5815.
74. W. Zhong, J. N. Feder, M. M. Jiang, L. Y. Jan and Y. N. Jan, Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis, Neuron 17 (1996), 43-53.
75. Q. Shen, W. Zhong, Y. N. Jan and S. Temple, Asymmetric Numb distribution is critical for asymmetric cell division of mouse cerebral cortical stem cells and neuroblasts, Development 129 (2002), 4843-4853.
76. T. Lechler and E. Fuchs, Asymmetric cell divisions promote stratification and differentiation of mammalian skin, Nature 437 (2005), 275-280.
77. A. Chenn and S. K. McConnell, Cleavage orientation and the asymmetric inheritance of Notch1 immunoreactivity in mammalian neurogenesis, Cell 82 (1995), 631-641.
78. S. Pece, M. Serresi, E. Santolini, M. Capra, E. Hulleman, V. Galimberti, S. Zurrida, P. Maisonneuve, G. Viale and P. P. Di Fiore, Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis, J Cell Biol 167 (2004), 215-221.
79. S. Stylianou, R. B. Clarke, and K. Brennan, Aberrant activation of notch signaling in human breast cancer, Cancer Res 66 (2006), 1517-1525.
80. R. P. Regala, C. Weems, L. Jamieson, A. Khoor, E. S. Edell, C. M. Lohse and A. P. Fields, Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer, Cancer Res 65 (2005), 8905-8911.
81. E. Gilson and V. Geli, How telomeres are replicated, Nat Rev Mol Cell Biol 8 (2007), 825-838.
82. S. He, D. Nakada and S. J. Morrison,Mechanisms of stem cell self-renewal, Annu Rev Cell Dev Biol 25 (2009), 377-406.
83. J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I. A. Sesterhenn, D. G. McLeod, S. Srivastava and J. S. Rhim, Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT-Immortalized PrimaryNonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens 1, Cancer Res 67 (2007), 3153-3161.
84. E. L. Carpenter and R. H. Vonderheide, Telomerase-based immunotherapy ofcancer 1, Expert Opin Biol Ther 6 (2006), 1031-1039.
85. C. Y. Logan and R. Nusse, The Wnt signaling pathway in development and disease, Annu Rev Cell Dev Biol 20 (2004), 781-810.
86. C. Blanpain, V. Horsley and E. Fuchs, Epithelial stem cells: turning over new leaves, Cell 128 (2007), 445-458.
87. N. Reguart, B. He, M. Taron, L. You, D. M. Jablons and R. Rosell, The role of Wnt signaling in cancer and stem cells 1, Fut Oncol 1 (2005), 787-797.
88. A. Ayyanan, G. Civenni, L. Ciarloni, C. Morel, N. Mueller, K. Lefort, A. Mandinova, W. Raffoul, M. Fiche, G. P. Dotto and C. Brisken, Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notchdependent mechanism, Proc Natl Acad Sci U S A 103 (2006), 3799-3804.
89. N. Hosen, T. Yamane, M. Muijtjens, K. Pham, M. F. Clarke and I. L. Weissmn, Bmi-1-green fluorescent protein (GFP)- knock-in mice reveal the dynamic regulation of Bmi-1 expression in normal and leukemic hematopoietic cells 1, Stem Cells (2007).
90. A. Z. Rizvi and M. H. Wong, Epithelial stem cells and their niche: there's no place like home, Stem Cells 23 (2005), 150-165.
91. T. Kondo, Brain cancer stem-like cells, Eur J Cancer 42 (2006), 1237-1242.
92. A. Wodarz and R. Nusse, Mechanisms of Wnt signaling in development, Annu Rev Cell Dev Biol 14 (1998), 59-88.
93. 93] X. He, Unwinding a path to nuclear beta-catenin, Cell 127 (2006), 40-42.
94. T. Reya and H. Clevers, Wnt signalling in stem cells and cancer, Nature 434 (2005), 843-850.
95. G. Turashvili, J. Bouchal, G. Burkadze and Z. Kolar, Wnt signaling pathway in mammary gland development and carcinogenesis, Pathobiology 73 (2006), 213-223.
96. T. C. He, A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein and K. W. Kinzler, Identification of c-MYC as a target of the APC pathway, Science 281 (1998), 1509-1512.
97. D. Pinto, A. Gregorieff, H. Begthel andH. Clevers, Canonical Wnt signals are essential for homeostasis of the intestinal epithelium, Genes Dev 17 (2003), 1709-1713.
98. C. van Genderen, R. M. Okamura, I. Farinas, R. G. Quo, T. G. Parslow, L. Bruhn and R. Grosschedl, Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice, Genes Dev 8 (1994), 2691-2703.
99. J. M. Mariadason, M. Bordonaro, F. Aslam, L. Shi, M. Kuraguchi, A. Velcich and L. H. Augenlicht, Downregulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation, Cancer Res 61 (2001), 3465-3471.
100. W. de Lau, N. Barker and H. Clevers, WNT signaling in the normal intestine and colorectal cancer, Front Biosci 12 (2007), 471-491.
101. J. Huelsken, R. Vogel, B. Erdmann, G. Cotsarelis and W. Birchmeier, beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin, Cell 105 (2001), 533-545.
102. M. I. Koster, K. A. Huntzinger and D. R. Roop, Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation, J Investig Dermatol Symp Proc 7 (2002), 41-45.
103. N. Barker, G. Huls, V. Korinek and H. Clevers, Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium, Am J Pathol 154 (1999), 29-35.
104. C. A. Gregory, A. Green, N. Lee, A. Rao and W. Gunn, The promise of canonical Wnt signaling modulators in enhancing bone repair, Drug News Perspect 19 (2006), 445-452.
105. C. A. Gregory,W. G. Gunn, E. Reyes, A. J. Smolarz, J. Munoz, J. L. Spees and D. J. Prockop, HowWnt signaling affects bone repair by mesenchymal stem cells from the bone marrow, Ann N Y Acad Sci 1049 (2005), 97-106.
106. A. Villanueva, P. Newell, D. Y. Chiang, S. L. Friedman and J. M. Llovet, Genomics and signaling pathways in hepatocellular carcinoma, Semin Liver Dis 27 (2007), 55-76.
107. J. Ross and L. Li, Recent advances in understanding extrinsic control of hematopoietic stem cell fate, Curr. Opin. Hematol. 13 (2006), 237-242.
108. Z. Borok, C. Li, J. Liebler, N. Aghamohammadi, V. A. Londhe and P. Minoo, Developmental pathways and specificationof intrapulmonary stem cells, Pediatr Res 59 (2006), 84R- 93R.
109. G. W. Yardy and S. F. Brewster, Wnt signalling and prostate cancer, Prostate Cancer Prostatic Dis 8 (2005), 119-126.
110. C. Blanpain, W. E. Lowry, A. Geoghegan, L. Polak and E. Fuchs, Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche, Cell 118 (2004), 635-648.
111. H. Nguyen, M. Rendl and E. Fuchs, Tcf3 governs stem cell features and represses cell fate determination in skin, Cell 127 (2006), 171-183.
112. V. Korinek, N. Barker, P. Moerer, E. van Donselaar, G. Huls, P. J. Peters and H. Clevers, Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4, Nat Genet 19 (1998), 379-383.
113. W. E. Lowry, C. Blanpain, J. A. Nowak, G. Guasch, L. Lewis and E. Fuchs, Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells, Genes Dev 19 (2005), 1596-1611.
114. T. Andl, K. Ahn, A. Kairo, E. Y. Chu, L. Wine-Lee, S. T. Reddy, N. J. Croft, J. A. Cebra-Thomas, D. Metzger, P. Chambon, K. M. Lyons, Y. Mishina, J. T. Seykora, E. B. Crenshaw, III and S. E. Millar, Epithelial Bmpr1a regulates differentiation and proliferation in postnatal hair follicles and is essential for tooth development, Development 131 (2004), 2257-2268.
115. H. Kalirai and R. B. Clarke, Human breast epithelial stem cells and their regulation, J Pathol 208 (2006), 7-16.
116. E. Batlle, J. T. Henderson, H. Beghtel, M. M. van den Born, E. Sancho, G. Huls, J. Meeldijk, J. Robertson, W. M. van de, T. Pawson and H. Clevers, Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB, Cell 111 (2002), 251-263.
117. J. Holmberg, M. Genander, M. M. Halford, C. Anneren, M. Sondell, M. J. Chumley, R. E. Silvany, M. Henkemeyer and J. Frisen, EphB receptors coordinate migration and proliferation in the intestinal stem cell niche, Cell 125 (2006), 1151-1163.
118. Y. Li, B. Welm, K. Podsypanina, S. Huang, M. Chamorro, X. Zhang, T. Rowlands, M. Egeblad, P. Cowin, Z. Werb, L. K. Tan, J. M. Rosen and H. E. Varmus, Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells, Proc Natl Acad Sci U S A 100 (2003), 15853-15858.
119. P. Polakis, Wnt signaling and cancer, Genes Dev 14 (2000), 1837-1851.
120. M. Bienz and H. Clevers, Linking colorectal cancer to Wnt signaling, Cell 103 (2000), 311-320.
121. L. Mishra, K. Shetty, Y. Tang, A. Stuart and S. W. Byers, The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer, Oncogene 24 (2005), 5775-5789.
122. A. Jung, M. Schrauder, U. Oswald, C. Knoll, P. Sellberg, R. Palmqvist, G. Niedobitek, T. Brabletz and T. Kirchner, The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation, Am J Pathol 159 (2001), 1613-1617.
123. T. Brabletz, A. Jung, S. Reu, M. Porzner, F. Hlubek, L. A. Kunz-Schughart, R. Knuechel and T. Kirchner, Variable betacatenin expression in colorectal cancers indicates tumor progression driven by the tumor environment, Proc Natl Acad Sci U S A 98 (2001), 10356-10361.
124. T. Kirchner and T. Brabletz, Patterning and nuclear betacatenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation, Am J Pathol 157 (2000), 1113-1121.
125. T. Brabletz, A. Jung, S. Spaderna, F. Hlubek and T. Kirchner, Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression, Nat Rev Cancer 5 (2005), 744-749.
126. J. Teuliere, M. M. Faraldo, M. A. Deugnier, M. Shtutman, A. Ben Ze'ev, J. P. Thiery and M. A. Glukhova, Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia, Development 132 (2005), 267-277.
127. A. S. Tsukamoto, R. Grosschedl, R. C. Guzman, T. Parslow and H. E. Varmus, Expression of the int-1 gene in transgenic mice is associated withmammary gland hyperplasia and adenocarcinoas in male and female mice, Cell 55 (1988), 619-625.
128. S. Y. Lin,W. Xia, J. C. Wang, K. Y. Kwong, B. Spohn, Y. Wen, R. G. Pestell and M. C. Hung, Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression, Proc Natl Acad Sci U S A 97 (2000), 4262-4266.
129. B. Y. Liu, S. P. McDermott, S. S. Khwaja and C. M. Alexander, The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells, Proc Natl Acad Sci U S A 101 (2004), 4158-4163.
130. R. H. Zurawel, S. A. Chiappa, C. Allen and C. Raffel, Sporadic medulloblastomas contain oncogenic beta-cateninmutations, Cancer Res 58 (1998), 896-899.
131. R. P. Dahmen, A. Koch, D. Denkhaus, J. C. Tonn, N. Sorensen, F. Berthold, J. Behrens, W. Birchmeier, O. D. Wiestler and T. Pietsch, Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas, Cancer Res 61 (2001), 7039-7043.
132. N. I. Khan and L. J. Bendall, Role ofWNT signaling in normal and malignant hematopoiesis, Histol Histopathol 21 (2006), 761-774.
133. W. A. Schulz, Understanding urothelial carcinoma through cancer pathways, Int J Cancer 119 (2006), 1513-1518.
134. B. He, R. N. Barg, L. You, Z. Xu, N. Reguart, I. Mikami, S. Batra, R. Rosell and D. M. Jablons, Wnt signaling in stem cells and non-small-cell lung cancer, Clin Lung Cancer 7 (2005), 54-60.
135. L. Strizzi, K. M. Hardy, E. A. Seftor, F. F. Costa, D. A. Kirschmann, R. E. Seftor, L. M. Postovit and M. J. Hendrix, Development and cancer: at the crossroads of Nodal and Notch signaling, Cancer Res 69 (2009), 7131-7134.
136. S. Artavanis-Tsakonas, M. D. Rand and R. J. Lake, Notch signaling: cell fate control and signal integration in development, Science 284 (1999), 770-776.
137. N. Schroder and A. Gossler, Expression of Notch pathway components in fetal and adult mouse small intestine, Gene xpr Patterns 2 (2002), 247-250.
138. S. Chiba, Notch signaling in stem cell systems, Stem Cells 24 (2006), 2437-2447.
139. M. Roy, W. S. Pear and J. C. Aster, The multifaceted role of Notch in cancer, Curr Opin Genet Dev 17 (2007), 52-59.
140. N. J. Savill and J. A. Sherratt, Control of epidermal stem cell clusters by Notch-mediated lateral induction, Dev Biol 258 (2003), 141-153.
141. C. Blanpain and E. Fuchs, Epidermal stem cells of the skin, Annu Rev Cell Dev Biol 22 (2006), 339-373.
142. N. Yamamoto, K. Tanigaki, H. Han, H. Hiai and T. Honjo, Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells, Curr Biol 13 (2003), 333-338.
143. Y. Pan, M. H. Lin, X. Tian, H. T. Cheng, T. Gridley, J. Shen and R. Kopan, gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis, Dev Cell 7 (2004), 731-743.
144. A. Rangarajan, C. Talora, R. Okuyama,M. Nicolas, C. Mammucari, H. Oh, J. C. Aster, S. Krishna, D. Metzger, P. Chambon, L. Miele, M. Aguet, F. Radtke and G. P. Dotto, Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation, EMBO J 20 (2001), 3427-3436.
145. T. Suzuki and S. Chiba, Notch signaling in hematopoietic stem cells, Int J Hematol 82 (2005), 285-294.
146. J. C. Pui, D. Allman, L. Xu, S. DeRocco, F. G. Karnell, S. Bakkour, J. Y. Lee, T. Kadesch, R. R. Hardy, J. C. Aster and W. S. Pear, Notch1 expression in early lymphopoiesis influences B versus T lineage determination, Immunity 11 (1999), 299-308.
147. A. Wilson, H. R. MacDonald and F. Radtke, Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus, J ExpMed 194 (2001), 1003-1012.
148. B. K. Hadland, N. R. Manley, D. Su, G. D. Longmore, C. L. Moore, M. S. Wolfe, E. H. Schroeter and R. Kopan, Gamma -secretase inhibitors repress thymocyte development, Proc Natl Acad Sci U S A 98 (2001), 7487-7491.
149. S. M. Lehar, J. Dooley, A. G. Farr and M. J. Bevan, Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors, Blood 105 (2005), 1440-1447.
150. K. Tanigaki, H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano and T. Honjo, Notch-RBPJ signaling is involved in cell fate determination of marginal zone B cells, Nat Immunol 3 (2002), 443-450.
151. K. Hozumi, N. Negishi, D. Suzuki, N. Abe, Y. Sotomaru, N. Tamaoki, C. Mailhos, D. Ish-Horowicz, S. Habu and M. J. Owen, Delta-like 1 is necessary for the generation ofmarginal zone B cells but not T cells in vivo, Nat Immunol 5 (2004), 638-644.
152. J. Jensen, E. E. Pedersen, P. Galante, J. Hald, R. S. Heller, M. Ishibashi, R. Kageyama, F. Guillemot, P. Serup and O. D. Madsen, Control of endodermal endocrine development by Hes-1, Nat Genet 24 (2000), 36-44.
153. K. Suzuki, H. Fukui, T. Kayahara M. Sawada, H. Seno, H. Hiai, R. Kageyama, H. Okano and T. Chiba, Hes1-deficient mice show precocious differentiation of Paneth cells in the small intestine, Biochem Biophys Res Commun 328 (2005), 348-352.
154. G. H. Searfoss, W. H. Jordan, D. O. Calligaro, E. J. Galbreath, L. M. Schirtzinger, B. R. Berridge, H. Gao,M. A. Higgins, P. C. May and T. P. Ryan, Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor, J Biol Chem 278 (2003), 46107-46116.
155. J. H. van Es, M. E. van Gijn, O. Riccio, B. M. van den, M. Vooijs, H. Begthel, M. Cozijnsen, S. Robine, D. J. Winton, F. Radtke and H. Clevers, Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature 435 (2005), 959-963.
156. Q. Yang, N. A. Bermingham, M. J. Finegold and H. Y. Zoghbi, Requirement ofMath1 for secretory cell lineage commitment in the mouse intestine, Science 294 (2001), 2155-2158.
157. Y. Katoh and M. Katoh, Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review), Int J Mol Med 18 (2006), 1019-1023.
158. K. D. Buono, G. W. Robinson, C. Martin, S. Shi, P. Stanley, K. Tanigaki, T. Honjo and L. Hennighausen, The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy, Dev Biol 293 (2006), 565-580.
159. K. Tanigaki, F. Nogaki, J. Takahashi, K. Tashiro, H. Kurooka and T. Honjo, Notch1 andNotch3 instructively restrict bFGFresponsive multipotent neural progenitor cells to an astroglial fate, Neuron 29 (2001), 45-55.
160. S. Hitoshi, T. Alexson, V. Tropepe, D. Donoviel, A. J. Elia, J. S. Nye, R. A. Conlon, T. W. Mak, A. Bernstein and K. D. van der, Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells, Genes Dev 16 (2002), 846-858.
161. M. Ishibashi, S. L. Ang, K. Shiota, S. Nakanishi, R. Kageyama and F. Guillemot, Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects, Genes Dev 9 (1995), 3136-3148.
162. M. Hojo, T. Ohtsuka, N. Hashimoto, G. Gradwohl, F. Guillemot and R. Kageyama, Glial cell fate specification modulated by the bHLH gene Hes5 in mouse retina, Development 127 (2000), 2515-2522.
163. C. A. Collins, I. Olsen, P. S. Zammit, L. Heslop, A. Petrie, T. A. Partridge and J. E. Morgan, Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche, Cell 122 (2005), 289-301.
164. M. Reedijk, S. Odorcic, L. Chang, H. Zhang, N. Miller, D. R. McCready, G. Lockwood and S. E. Egan, High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival, Cancer Res 65 (2005), 8530-8537.
165. T. A. Bismar, F. Demichelis, A. Riva, R. Kim, S. Varambally, L. He, J. Kutok, J. C. Aster, J. Tang, R. Kuefer, M. D. Hofer, P. G. Febbo, A. M. Chinnaiyan and M. A. Rubin, Defining aggressive prostate cancer using a 12-gene model, Neoplasia 8 (2006), 59-68.
166. B. B. Tysnes and R. Bjerkvig, Cancer initiation and progression: Involvement of stem cells and the microenvironment, Biochim Biophys Acta (2007).
167. Z. Yao and L. Mishra, Cancer stem cells and hepatocellular carcinoma, Cancer Biol Ther 8 (2009), 1691-1698.
168. M. Nicolas, A. Wolfer, K. Raj, J. A. Kummer, P. Mill, M. van Noort, C. C. Hui, H. Clevers, G. P. Dotto and F. Radtke, Notch1 functions as a tumor suppressor in mouse skin, Nat Genet 33 (2003), 416-421.
169. S. K. Mungamuri, X. Yang, A. D. Thor and K. Somasundaram, Survival signalingzby Notch1: mammalian target of apamycin (mTOR)-dependen inhibition of p53, Cancer Res 66 (2006), 4715-4724.
170. Y. Sun, W. Lowther, K. Kato, C. Bianco, N. Kenney, L. Strizzi, D. Raafat, M. Hirota, N. I. Khan, S. Bargo, B. Jones, D. Salomon and R. Callahan, Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling, Oncogene 24 (2005), 5365-5374.
171. K. Balint, M. Xiao, C. C. Pinnix, A. Soma, I. Veres, I. Juhasz, E. J. Brown, A. J. Capobianco, M. Herlyn and Z. J. Liu, Activation of Notch1 signaling is required for beta-cateninmediated human primary melanoma progression, J Clin Invest 115 (2005), 3166-3176.
172. S. Pahlman, M. T. Stockhausen, E. Fredlund and H. Axelson, Notch signaling in neuroblastoma, Semin Cancer Biol 14 (2004), 365-373.
173. A. R. Hallahan, J. I. Pritchard, S. Hansen, M. Benson, J. Stoeck, B. A. Hatton, T. L. Russell, R. G. Ellenbogen, I. D. Bernstein, P. A. Beachy and J. M. Olson, The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas, Cancer Res 64 (2004), 7794-7800.
174. J. T. Park, M. Li, K. Nakayama, T. L. Mao, B. Davidson, Z. Zhang, R. J. Kurman, C. G. Eberhart, I. Shih and T. L. Wang, Notch3 gene amplification in ovarian cancer, Cancer Res 66 (2006), 6312-6318.
175. F. Radtke, H. Clevers and O. Riccio, From gut homeostasis to cancer, Curr Mol Med 6 (2006), 275-289.
176. B. W. Purow, R. M. Haque, M. W. Noel, Q. Su, M. J. Burdick, J. Lee, T.
177. M. Ramalho-Santos, D. A. Melton and A. P. McMahon, Hedgehog signals regulate multiple aspects of gastrointestinal development, Development 127 (2000), 2763-2772
178. M. E. Hutchin, M. S. Kariapper, M. Grachtchouk, A. Wang, L. Wei, D. Cummings, J. Liu, L. E. Michael, A. Glick and A. A. Dlugosz, Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle, Genes Dev 19 (2005), 214-223.
179. V. Palma and A. Altaba, Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex, Development 131 (2004), 337-345
180. S. Liu, G. Dontu and M. S. Wicha, Mammary stem cells, selfrenewal pathways, and carcinogenesis, Breast Cancer Res 7 (2005), 86-95.
181. H. Kawahira, D. W. Scheel, S. B. Smith, M. S. German and M. Hebrok, Hedgehog signaling regulates expansion of pancreatic epithelial cells, Dev Biol 280 (2005), 111-121.
182. G. R. van den Brink, S. A. Bleuming, J. C. Hardwick, B. L. Schepman, G. J. Offerhaus, J. J. Keller, C. Nielsen, W. Gaffield, S. J. van Deventer, D. J. Roberts and M. P. Peppelenbosch, Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation, Nat Genet 36 (2004), 277-282.
183. B. St Jacques, H. R. Dassule, I. Karavanova, V. A. Botchkarev, J. Li, P. S. Danielian, J. A. McMahon, P. M. Lewis, R. Paus and A. P. McMahon, Sonic hedgehog signaling is essential for hair development, Curr Biol 8 (1998), 1058-1068.
184. C. Chiang, R. Z. Swan, M. Grachtchouk, M. Bolinger, Y. Litingtung, E. K. Robertson, M. K. Cooper, W. Gaffield, H. Westphal, P. A. Beachy and A. A. Dlugosz, Essential role for Sonic hedgehog during hair follicle morphogenesis, Dev Biol 205 (1999), 1-9.
185. H. L. Park, C. Bai, K. A. Platt, M. P. Matise, A. Beeghly, C. C. Hui, M. Nakashima and A. L. Joyner, Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation, Development 127 (2000), 1593-1605.
186. K. W. Kinzler, S. H. Bigner, D. D. Bigner, J. M. Trent, M. L. Law, S. J. O'Brien, A. J. Wong and B. Vogelstein, Identification of an amplified, highly expressed gene in a human glioma, Science 236 (1987), 70-73.
187. A. Altaba, P. Sanchez and N. Dahmane, Gli and hedgehog in cancer: tumours, embryos and stem cells, Nat Rev Cancer 2 (2002), 361-372.
188. L. V. Goodrich, L. Milenkovic, K. M. Higgins and M. P. Scott, Altered neural cell fates and medulloblastoma in mouse patched mutants, Science 277 (1997), 1109-1113.
189. C. Raffel, R. B. Jenkins, L. Frederick, D. Hebrink, B. Alderete, D. W. Fults and C. D. James, Sporadic medulloblastomas contain PTCH mutations, Cancer Res 57 (1997), 842-845.
190. A. E. Oro, K. M. Higgins, Z. Hu, J. M. Bonifas, E. H. Epstein, Jr. and M. P. Scott, Basal cell carcinomas in mice overexpressing sonic hedgehog, Science 276 (1997), 817-821.
191. H. Hahn, C. Wicking, P. G. Zaphiropoulous, M. R. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A. B. Unden, S. Gillies, K. Negus, I. Smyth, C. Pressman, D. J. Leffell, B. Gerrard, A. M. Goldstein,M. Dean, R. Toftgard,G. Chenevix-Trench, B. Wainwright and A. E. Bale, Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome, Cell 85 (1996), 841-851.
192. V. Medina,M. B. Calvo, S. az-Prado and J. Espada, Hedgehog signalling as a target in cancer stem cells, Clin Transl Oncol 11 (2009), 199-207.
193. A. Hoffmann and G. Gross, BMP signaling pathways in cartilage and bone formation, Crit Rev Eukaryot Gene Expr 11 (2001), 23-45.
194. M. Bhatia, D. Bonnet, D. Wu, B. Murdoch, J. Wrana, L. Gallacher and J. E. Dick, Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells, J ExpMed 189 (1999), 1139-1148.
195. G. N. Hendy, H. Kaji, H. Sowa, J. J. Lebrun and L. Canaff, Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast, Horm Metab Res 37 (2005), 375-379.
196. V. A. Botchkarev, Bone morphogenetic proteins and their antagonists in skin and hair follicle biology, J Invest Dermatol 120 (2003), 36-47.
197. A. Ishizuya-Oka, Epithelial-connective tissue cross-talk is essential for regeneration of intestinal epithelium, J Nippon Med Sch 72 (2005), 13-18.
198. J. R. Howe, J. L. Bair, M. G. Sayed, M. E. Anderson, F. A. Mitros, G. M. Petersen, V. E. Velculescu, G. Traverso and B. Vogelstein, Germline mutations of the gene encoding bone morphogenetic protein receptor 1Ain juvenile polyposis, Nat Genet 28 (2001), 184-187.
199. C. Kawamura, M. Kizaki and Y. Ikeda, Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells, Leuk Lymphoma 43 (2002), 635-639.
200. M. Y. Hsu, S. Rovinsky, S. Penmatcha, M. Herlyn and D. Muirhead, Bonemorphogenetic proteins inmelanoma: angel or devil?, Cancer Metastasis Rev 24 (2005), 251-263.
201. N. Itasaki and S. Hoppler, Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship, Dev Dyn 239 (2010), 16-33.
202. J. Lessard and G. Sauvageau, Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells, Nature 423 (2003), 255-260.
203. A. V. Molofsky, R. Pardal, T. Iwashita, I. K. Park, M. F. Clarke and S. J. Morrison, Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation, Nature 425 (2003), 962-967.
204. G. P. Dimri, J. L. Martinez, J. J. Jacobs, P. Keblusek, K. Itahana, L. M. Van, J. Campisi, D. E. Wazer and V. Band, The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells 1, Cancer Res 62 (2002), 4736-4745.
205. I. K. Park, D. Qian, M. Kiel, M. W. Becker, M. Pihalja, I. L. Weissman, S. J. Morrison and M. F. Clarke, Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells, Nature 423 (2003), 302-305.
206. T. Maehama and J. E. Dixon, The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate 1, J Biol Chem 273 (1998), 13375-13378.
207. C. A. Di and P. P. Pandolfi, The multiple roles of PTEN in tumor suppression 1, Cell 100 (2000), 387-390.
208. O. H. Yilmaz, R. Valdez, B. K. Theisen, W. Guo, D. O. Ferguson, H. Wu and S. J. Morrison, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells 1, Nature 441 (2006), 475-482.
209. C. Pitsouli and N. Perrimon, Developmental biology: Our fly cousins' gut, Nature 454 (2008), 592-593.
210. C. Leung, M. Lingbeek, O. Shakhova, J. Liu, E. Tanger, P. Saremaslani, L. M. Van and S. Marino, Bmi1 is essential or cerebellar development and is overexpressed in human medulloblastomas 1, Nature 428 (2004), 337-341.
211. V. A. Botchkarev, N. V. Botchkareva, A. A. Sharov, K. Funa, O. Huber and B. A. Gilchrest, Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles, J Invest Dermatol 118 (2002), 3-10.
212. A. Shaw and W. Bushman, Hedgehog signaling in the prostate, J Urol 177 (2007), 832-838.
213. L. Kopper and M. Hajdu, Tumor stem cells 1, Pathol Oncol Res 10 (2004), 69-73.
214. A. Schulenburg, K. Bramswig, H. Herrmann, H. Karlic, I. Mirkina, R. Hubmann, S. Laffer, B. Marian, M. Shehata, C. Krepler, H. Pehamberger, T. Grunt, U. Jager, C. C. Zielinski and P. Valent, Neoplastic stem cells: Current concepts and clinical perspectives, Crit Rev Oncol Hematol (2010).
215. T. L. Holyoake, X. Jiang, H. G. Jorgensen, S. Graham, M. J. Alcorn, C. Laird, A. C. Eaves and C. J. Eaves, Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3, Blood 97 (2001), 720-728.
216. P. J. Fialkow, R. J. Jacobson and T. Papayannopoulou, Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/ macrophage, Am J Med 63 (1977), 125-130.
217. S. J. Morrison and I. L. Weissman, The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype, Immunity 1 (1994), 661-673.
218. J. E. Dick, Complexity of the human acute myeloid leukemia stem cell compartment: implications for therapy, Biol Blood Marrow Transplant 11 (2005), 9-11.
219. R. O. Casasnovas, F. K. Slimane, R. Garand, G. C. Faure, L. Campos, V. Deneys, M. Bernier, A. Falkenrodt, G. Lecalvez, M. Maynadie and M. C. Bene, Immunological classification of acute myeloblastic leukemias: relevance to patient outcome, Leukemia 17 (2003), 515-527.
220. S. Florian, K. Sonneck, A. W. Hauswirth, M. T. Krauth, G. H. Schernthaner, W. R. Sperr and P. Valent, Detection of molecular targets on the surface of CD34+/CD38 - stem cells in various myeloid malignancies, Leuk. Lymphoma 47 (2006), 207-222.
221. D. Hong, R. Gupta, P. Ancliff, A. Atzberger, J. Brown, S. Soneji, J. Green, S. Colman, W. Piacibello, V. Buckle, S. Tsuzuki, M. Greaves and T. Enver, Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia, Science 319 (2008), 336-339.
222. Y. Kong, S. Yoshida, Y. Saito, T. Doi, Y. Nagatoshi, M. Fukata, N. Saito, S. M. Yang, C. Iwamoto, J. Okamura, K. Y. Liu, X. J. Huang, D. P. Lu, L. D. Shultz, M. Harada and F. Ishikawa, CD34+CD38+CD19+ as well as CD34+CD38- CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL, Leukemia 22 (2008), 1207-1213.
223. H. Nishida, H. Yamazaki, T. Yamada, S. Iwata, N. H. Dang, T. Inukai, K. Sugita, Y. Ikeda and C. Morimoto, CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells, Biochem Biophys Res Commun 382 (2009), 57-62.
224. H. Yamazaki, H. Nishida, S. Iwata, N. H. Dang and C. Morimoto, CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells, Biochem Biophys Res Commun 383 (2009), 172-177.
225. W. Matsui, C. A. Huff, Q. Wang, M. T. Malehorn, J. Barber, Y. Tanhehco, B. D. Smith, C. I. Civin and R. J. Jones, Characterization of clonogenic multiple myeloma cells 1, Blood 103 (2004), 2332-2336.
226. T. Rasmussen, M. Lodahl, S. Hancke and H. E. Johnsen, In multiple myeloma clonotypic, Leuk Lymphoma 45 (2004), 1413-1417.
227. W. Matsui, Q. Wang, J. P. Barber, S. Brennan, B. D. Smith, I. Borrello, I. McNiece, L. Lin, R. F. Ambinder, C. Peacock, D. N. Watkins, C. A. Huff and R. J. Jones, Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance, Cancer Res 68 (2008), 190-197.
228. B. J. Huntly and D. G. Gilliland, Leukaemia stem cells and the evolution of cancer-stem-cell research, Nat Rev Cancer 5 (2005), 311-321.
229. L. Pevny and M. S. Rao, The stem-cell menagerie, Trends Neurosci 26 (2003), 351-359.
230. G. J. Pilkington, Cancer stem cells in the mammalian central nervous system 1, Cell Prolif 38 (2005), 423-433.
231. S. V. Shmelkov, C. R. St, D. Lyden and S. Rafii, AC133/CD133/Prominin-1 1, Int J Biochem Cell Biol 37 (2005), 715-719.
232. A. H. Yin, S. Miraglia, E. D. Zanjani, G. meida-Porada, M. Ogawa, A. G. Leary, J. Olweus, J. Kearney and D. W. Buck, AC133, a novel marker for human hematopoietic stem and progenitor cells 1, Blood 90 (1997), 5002-5012.
233. M. Peichev, A. J. Naiyer, D. Pereira, Z. Zhu, W. J. Lane, M. Williams, M. C. Oz, D. J. Hicklin, L. Witte, M. A. Moore and S. Rafii, Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors 1, Blood 95 (2000), 952-958.
234. N. Uchida, D. W. Buck, D. He,M. J. Reitsma, M. Masek, T. V. Phan, A. S. Tsukamoto, F. H. Gage and I. L. Weissman, Direct isolation of human central nervous system stem cells 1, Proc Natl Acad Sci U S A 97 (2000), 14720-14725.
235. G. D. Richardson, C. N. Robson, S. H. Lang, D. E. Neal, N. J. Maitland and A. T. Collins, CD133, a novelmarker for human prostatic epithelial stem cells 1, J Cell Sci 117 (2004), 3539-3545.
236. S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, R. E. McLendon, A. B. Hjelmeland and J. N. Rich, Targeting cancer stem cells through L1CAM suppresses glioma growth, Cancer Res 68 (2008), 6043-6048.
237. M. Ehtesham, K. Y. Mapara, C. B. Stevenson and R. C. Thompson, CXCR4 mediates the proliferation of glioblastoma progenitor cells, Cancer Lett 274 (2009), 305-312.
238. T. A. Read, M. P. Fogarty, S. L. Markant, R. E. McLendon, Z. Wei, D. W. Ellison, P. G. Febbo and R. J. Wechsler-Reya, Identificatio of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma, Cancer Cell 15 (2009), 135-147.
239. A. Treister, O. Sagi-Assif, M. Meer, N. I. Smorodinsky, R. Anavi, I. Golan, T. Meshel, O. Kahana, R. Eshel, B. Z. Katz, E. Shevach and I. P. Witz, Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress 1, Int J Cancer 77 (1998), 306-313.
240. B. E. Welm, S. B. Tepera, T. Venezia, T. A. Graubert, J. M. Rosen and M. A. Goodell, Sca-1(pos) cells in themousemammary gland represent an enriched progenitor cell population, Dev Biol 245 (2002), 42-56.
241. A. J. Alvi, H. Clayton, C. Joshi, T. Enver, A. Ashworth, M. M. Vivanco, T. C. Dale andM. J. Smalley, Functional andmolecular haracterisation ofmammary side population cells, Breast Cancer Res 5 (2003), R1-R8.
242. C. Li, D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsay, M. Wicha, M. F. Clarke and D. M. Simeone, Identification of pancreatic cancer stem cells, Cancer Res 67 (2007), 1030-1037.
243. P. C. Hermann, S. L. Huber, T. Herrler, A. Aicher, J. W. Ellwart, M. Guba, C. J. Bruns and C. Heeschen, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell 1 (2007), 313-323.
244. S. Sell and H. L. Leffert, Liver cancer stem cells, J Clin Oncol 26 (2008), 2800-2805.
245. H. Taniguchi and T. Chiba, Stem cells and cancer in the liver, Dis Markers 24 (2008), 223-229.
246. T. K. Lee, A. Castilho, S. Ma and I. O. Ng, Liver cancer stem cells: implications for a new therapeutic target, Liver Int 29 (2009), 955-965.
247. S. Ma, T. K. Lee, B. J. Zheng, K. W. Chan and X. Y. Guan, CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway, Oncogene 27 (2008), 1749-1758.
248. Z. F. Yang, P. Ngai, D. W. Ho, W. C. Yu, M. N. Ng, C. K. Lau, M. L. Li, K. H. Tam, C. T. Lam, R. T. Poon and S. T. Fan, Identification of local and circulating cancer stem cells in human liver cancer, Hepatology 47 (2008), 919-928.
249. A. Schulenburg, P. Cech, I. Herbacek, B. Marian, F. Wrba, P. Valent and H. Ulrich-Pur, CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2), J Pathol 213 (2007), 152-160.
250. S. Takaishi, T. Okumura, S. Tu, S. S. Wang,W. Shibata, R. Vigneshwaran, S. A. Gordon, Y. Shimada and T. C. Wang, Identification of gastric cancer stem cells using the cell surface marker CD44, Stem Cells 27 (2009), 1006-1020.
251. M. E. Prince, R. Sivanandan, A. Kaczorowski, G. T. Wolf, M. J. Kaplan, P. Dalerba, I. L. Weissman, M. F. Clarke and L. E. Ailles, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proc Natl Acad Sci U S A 104 (2007), 973-978.
252. A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower and N. J. Maitland, Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res 65 (2005), 10946-10951.
253. N. J. Maitland and A. T. Collins, Prostate cancer stem cells: a new target for therapy, J Clin Oncol 26 (2008), 2862-2870.
254. S. Kasper, Exploring the origins of the normal prostate and prostate cancer stem cell, Stem Cell Rev 4 (2008), 193-201.
255. M. L. Suva, N. Riggi, J. C. Stehle, K. Baumer, S. Tercier, J. M. Joseph, D. Suva, V. Clement, P. Provero, L. Cironi, M. C. Osterheld, L. Guillou and I. Stamenkovic, Identification of cancer stem cells in Ewing's sarcoma, Cancer Res 69 (2009), 1776-1781.
256. V. Tirino, R. Camerlingo, R. Franco, D. Malanga, R. A. La, G. Viglietto, G. Rocco and G. Pirozzi, The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer, Eur J Cardiothorac Surg 36 (2009), 446-453.
257. T. Baba, P. A. Convery, N. Matsumura, R. S. Whitaker, E. Kondoh, T. Pery, Z. Huang, R. C. Bentley, S. Mori, S. Fujii, J. R. Marks, A. Berchuck and S. K. Murphy, Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells, Oncogene 28 (2009), 209-218.
258. E. Goossens and H. Tournaye, Testicular stem cells 1, Semin Reprod Med 24 (2006), 370-378.
259. A. I. Caplan, Mesenchymal stem cells, JOrthop Res 9 (1991), 641-650.
260. E. A. Jones, S. E. Kinsey, A. English, R. A. Jones, L. Straszynski, D. M. Meredith, A. F. Markham, A. Jack, P. Emery and D. McGonagle, Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells, Arthritis Rheum 46 (2002), 3349-3360.
261. H. J. Buhring, V. L. Battula, S. Treml, B. Schewe, L. Kanz and W. Vogel, Novel markers for the prospective isolation of human MSC, Ann N Y Acad Sci (2007).
262. R. Sackstein, J. S. Merzaban, D. W. Cain, N. M. Dagia, J. A. Spencer, C. P. Lin and R. Wohlgemuth, Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone, NatMed 14 (2008), 181-187.
263. D. C. Taussig, F. Miraki-Moud, F. njos-Afonso, D. J. Pearce, K. Allen, C. Ridler, D. Lillington, H. Oakervee, J. Cavenagh, S. G. Agrawal, T. A. Lister, J. G. Gribben and D. Bonnet, Anti- CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells, Blood 112 (2008), 568-575.
264. F. Ishikawa, Y. Saito, S. Yoshida, M. Harada and L. D. Shultz, The differentiative and regenerative properties of human hematopoietic stem/progenitor cells in NOD-SCID/ IL2rgamma(null) mice, Curr Top Microbiol Immunol 324 (2008), 87-94.
265. Z. F. Yang, D. W. Ho, M. N. Ng, C. K. Lau, W. C. Yu, P. Ngai, P. W. Chu, C. T. Lam, R. T. Poon and S. T. Fan, Significance of CD90+ cancer stem cells in human liver cancer, Cancer Cell 13 (2008), 153-166.
266. S. Zhou, J. D. Schuetz, K. D. Bunting, A. M. Colapietro, J. Sampath, J. J. Morris, I. Lagutina, G. C. Grosveld, M. Osawa, H. Nakauchi and B. P. Sorrentino, The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nat Med 7 (2001), 1028-1034.
267. C. W. Scharenberg, M. A. Harkey and B. Torok-Storb, The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors, Blood 99 (2002), 507-512.
268. H. Kusuhara and Y. Sugiyama, ATP-binding cassette, subfamily G (ABCG family), Pflugers Arch 453 (2007), 735-744.
269. C. Hu, H. Li, J. Li, Z. Zhu, S. Yin, X. Hao, M. Yao, S. Zheng and J. Gu, Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling, Carcinogenesis 29 (2008), 2289-2297.
270. M. A. Goodell, K. Brose, G. Paradis, A. S. Conner and R. C. Mulligan, Isolation and functional properties of murinehematopoietic s em cells that are replicating in vivo 1, J Exp Med 183 (1996), 1797-1806.
271. M. Kim, H. Turnquist, J. Jackson, M. Sgagias, Y. Yan, M. Gong, M. Dean, J. G. Sharp and K. Cowan, The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells, Clin Cancer Res 8 (2002), 22-28.
272. S. Bhattacharya, J. D. Jackson, A. V. Das, W. B. Thoreson, C. Kuszynski, J. James, S. Joshi and I. Ahmad, Direct identification and enrichment of retinal stem cells/progenitors by Hoechst dye efflux assay, Invest Ophthalmol Vis Sci 44 (2003), 2764-2773.
273. R. B. Clarke, Isolation and characterization of human mammary stem cells 1, Cell Prolif 38 (2005), 375-386.
274. W. A. Woodward, M. S. Chen, F. Behbod and J. M. Rosen, On mammary stem cells, J Cell Sci 118 (2005), 3585-3594.
275. C. Wu and B. A. Alman, Side population cells in human cancers, Cancer Lett 268 (2008), 1-9.
276. N. A. Sophos and V. Vasiliou, Aldehyde dehydrogenase gene superfamily: the 2002 update 2, Chem Biol Interact 143-144 (2003), 5-22.
277. R. W. Storms, A. P. Trujillo, J. B. Springer, L. Shah, O. M. Colvin, S. M. Ludeman and C. Smith, Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity 1, Proc NatlAcad SciUSA 96 (1999), 9118-9123.
278. J. Cai, A. Cheng, Y. Luo, C. Lu, M. P. Mattson, M. S. Rao and K. Furukawa, Membrane properties of rat embryonic multipotent neural stem cells, J Neurochem 88 (2004), 212-226.
279. R. J. Jones, J. P. Barber, M. S. Vala, M. I. Collector, S. H. Kaufmann, S. M. Ludeman, O. M. Colvin and J. Hilton, Assessment of aldehyde dehydrogenase in viable cells 1, Blood 85 (1995), 2742-2746.
280. D. J. Pearce, D. Taussig, C. Simpson, K. Allen, A. Z. Rohatiner, T. A. Lister and D. Bonnet, Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples 1, Stem Cells 23 (2005), 752-760.
281. J. S. Wang, Q. Fang, D. J. Sun, J. Chen, X. L. Zhou, G. W. Lin, H. Z. Lu and J. Fei, Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin 1, Acta Pharmacol Sin 22 (2001), 949-955.
282. Y. Su, Q. Qiu, X. Zhang, Z. Jiang, Q. Leng, Z. Liu, S. A. Stass and F. Jiang, Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer, Cancer Epidemiol Biomarkers Prev 19 (2010), 327-337.
283. E. Charafe-Jauffret, C. Ginestier, F. Iovino, C. Tarpin, M. Diebel, B. Esterni, G. Houvenaeghel, J. M. Extra, F. Bertucci, J. Jacquemier, L. Xerri, G. Dontu, G. Stassi, Y. Xiao, S. H. Barsky, D. Birnbaum, P. Viens and M. S. Wicha, Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer, Clin Cancer Res 16 (2010), 45-55.
284. D. Ran, M. Schubert, L. Pietsch, I. Taubert, P. Wuchter, V. Eckstein, T. Bruckner, M. Zoeller and A. D. Ho, Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes, Exp Hematol 37 (2009), 1423-1434.
285. J. E. Carpentino, M. J. Hynes, H. D. Appelman, T. Zheng, D. A. Steindler, E. W. Scott and E. H. Huang, Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer, Cancer Res 69 (2009), 8208-8215.
286. M. R. Clay, M. Tabor, J. H. Owen, T. E. Carey, C. R. Bradford, G. T. Wolf,M. S. Wicha andM. E. Prince, Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase, Head Neck (2010).
287. R. Rozental, M. Morales, M. F. Mehler, M. Urban, M. Kremer, R. Dermietzel, J. A. Kessler and D. C. Spray, Changes in the properties of gap junctions during neuronal differentiation of hippocampal progenitor cells 1, J Neurosci 18 (1998), 1753-1762.
288. G. Sohl and K. Willecke, Gap junctions and the connexin protein family 1, Cardiovasc Res 62 (2004), 228-232.
289. S. C. Guthrie and N. B. Gilula, Gap junctional communication and development 1, Trends Neurosci 12 (1989), 12-16.
290. A. Warner, Gap junctions in development-a perspective 1, Semin Cell Biol 3 (1992), 81-91.
291. A. Pozzi, B. Risek, D. T. Kiang, N. B. Gilula and N. M. Kumar, Analysis of multiple gap junction gene products in the rodent and human mammary gland 1, Exp Cell Res 220 (1995), 212-219.
292. C. A. Presley, A. W. Lee, B. Kastl, I. Igbinosa, Y. Yamada, G. I. Fishman, D. E. Gutstein and J. A. Cancelas, Bonemarrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy 1, Cell Commun Adhes 12 (2005), 307-317.
293. J. M. Wolosin, M. T. Budak and M. A. Akinci, Ocular surface epithelial and stem cell development 2, Int J Dev Biol 48 (2004), 981-991.
294. V. Krutovskikh, G. Mazzoleni, N. Mironov, Y. Omori, A. M. Aguelon, M. Mesnil, F. Berger, C. Partensky and H. Yamasaki, Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32 1, Int J Cancer 56 (1994), 87-94.
295. E. A. Hanna, S. Umhauer, S. L. Roshong, M. P. Piechocki,M. J. Fernstrom, J. D. Fanning and R. J. Ruch, Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro 1, Carcinogenesis 20 (1999), 1369-1373.
296. H. Tsai, J. Werber, M. O. Davia, M. Edelman, K. E. Tanaka, A. Melman, G. J. Christ and J. Geliebter, Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells 1, Biochem Biophys Res Commun 227 (1996), 64-69.
297. P. P. Mehta, C. Perez-Stable, M. Nadji, M. Mian, K. Asotra and B. A. Roos, Suppression of human prostate cancer cell growth by forced expression of connexin genes 2, Dev Genet 24 (1999), 91-110.
298. T. J. King, L. H. Fukushima, A. D. Hieber, K. A. Shimabukuro, W. A. Sakr and J. S. Bertram, Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression 1, Carcinogenesis 21 (2000), 1097-1109.
299. T. Lapidot, A. Dar and O. Kollet, How do stem cells find their way home? 1, Blood 106 (2005), 1901-1910.
300. J. P. Chute, Stem cell homing 2, Curr Opin Hematol 13 (2006), 399-406.
301. T. Schioppa, B. Uranchimeg, A. Saccani, S. K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, A. Mantovani, G. Melillo and A. Sica, Regulation of the chemokine receptor CXCR4 by hypoxia 1, J ExpMed 198 (2003), 1391-1402.
302. G. Helbig, K. W. Christopherson, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K. D. Miller, H. E. Broxmeyer and H. Nakshatri, NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4 1, J Biol Chem 278 (2003), 21631-21638.
303. M. Z. Ratajczak, E. Zuba-Surma, M. Kucia, R. Reca, W. Wojakowski and J. Ratajczak, The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis 1, Leukemia 20 (2006), 1915-1924.
304. S. Gelmini, M. Mangoni, M. Serio, P. Romagnani and E. Lazzeri, The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis, J Endocrinol Invest 31 (2008), 809-819.
305. Y. R. Zou, A. H. Kottmann, M. Kuroda, I. Taniuchi and D. R. Littman, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development 1, Nature 393 (1998), 595-599.
306. R. J. Phillips, J. Mestas, M. Gharaee-Kermani, M. D. Burdick, A. Sica, J. A. Belperio, M. P. Keane and R. M. Strieter, Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3- kinase/PTEN/AKT/ mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor- 1alpha 1, J Biol Chem 280 (2005), 22473-22481.
307. J. A. Burger and D. J. Stewart, CXCR4 chemokine receptor antagonists: perspectives in SCLC, Expert Opin Investig Drugs 18 (2009), 481-490.
308. M. F. White, Insulin signaling in health and disease 1, Science 302 (2003), 1710-1711.
309. E. I. Fomchenko and E. C. Holland, Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment 1, Neurosurg Clin N Am 18 (2007), 39-58, viii.
310. E. Seuntjens, L. Umans, A. Zwijsen, M. Sampaolesi, C. M. Verfaillie and D. Huylebroeck, Transforming Growth Factor type beta and Smad family signaling in stem cell function, Cytokine Growth Factor Rev 20 (2009), 449-458.
311. A. V. Das, J. James, J. Rahnenfuhrer, W. B. Thoreson, S. Bhattacharya, X. Zhao and I. Ahmad, Retinal properties and potential of the adult mammalian ciliary epithelium stem cells 1, Vision Res 45 (2005), 1653-1666.
312. T. Yagi and M. Takeichi, Cadherin superfamily genes: functions, genomic organization, and neurologic diversity 1, Genes Dev 14 (2000), 1169-1180.
313. R. O. Hynes, Integrins: versatility, modulation, and signaling in cell adhesion 1, Cell 69 (1992), 11-25.
314. F. A. van der and A. Sonnenberg, Function and interactions of integrins 1, Cell Tissue Res 305 (2001), 285-298.
315. F. Kuphal and J. Behrens, E-cadherin modulates Wntdependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts 1, Exp Cell Res 312 (2006), 457-467.
316. D. E. White, J. H. Rayment and W. J. Muller, Addressing the role of cell adhesion in tumor cell dormancy 1, Cell Cycle 5 (2006), 1756-1759.
317. J. Nichols, B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe- Nebenius, I. Chambers, H. Scholer and A. Smith, Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4 1, Cell 95 (1998), 379-391.
318. S. Y. Hatano, M. Tada, H. Kimura, S. Yamaguchi, T. Kono, T. Nakano, H. Suemori, N. Nakatsuji and T. Tada, Pluripotential competence of cells associated with Nanog activity 1, Mech Dev 122 (2005), 67-79.
319. F. Cavaleri and H. R. Scholer, Nanog: a new recruit to the embryonic stem cell orchestra 1, Cell 113 (2003), 551-552.
320. J. Takeda, S. Seino and G. I. Bell, Human Oct3 gene family: cDNA sequences alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues 1, Nucleic Acids Res 20 (1992), 4613-4620.
321. M. H. Tai, C. C. Chang, M. Kiupel, J. D. Webster, L. K. Olson and J. E. Trosko, Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis 1, Carcinogenesis 26 (2005), 495-502.
322. H. Yu, D. Fang, S. M. Kumar, L. Li, T. K. Nguyen, G. Acs, M. Herlyn and X. Xu, Isolation of a novel population of multipotent adult stem cells from human hair follicles 1, Am J Pathol 168 (2006), 1879-1888.
323. K. Hochedlinger, Y. Yamada, C. Beard and R. Jaenisch, Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues 1, Cell 121 (2005), 465-477.
324. M. Monk and C. Holding, Human embryonic genes reexpressed in cancer cells 1, Oncogene 20 (2001), 8085-8091.
325. R. A. Steingart, E. Heldenberg, A. Pinhasov, D. E. Brenneman, M. Fridkin and I. Gozes, A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes 1, Life Sci 71 (2002), 2543-2552.
326. Y. Tanaka, T. Era, S. I. Nishikawa and S. Kawamata, Forced expression of Nanog in hematopoietic stem cells results in a {gamma}{delta}T cell disorder 1, Blood (2007).
327. P. Ellis, B. M. Fagan, S. T. Magness, S. Hutton, O. Taranova, S. Hayashi, A. McMahon, M. Rao and L. Pevny, SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult 1, Dev Neurosci 26 (2004), 148-165.
328. V. Episkopou, SOX2 functions in adult neural stem cells 1, Trends Neurosci 28 (2005), 219-221.
329. H. D. Hemmati, I. Nakano, J. A. Lazareff, M. Masterman- Smith, D. H. Geschwind, M. Bronner-Fraser and H. I. Kornblum, Cancerous stem cells can arise from pediatric brain tumors 1, Proc Natl Acad Sci U S A 100 (2003), 15178-15183.
330. S. Tabibzadeh and A. Hemmati-Brivanlou, Lefty at the crossroads of "stemness" and differentiative events 1, Stem Cells 24 (2006), 1998-2006.
331. G. Minchiotti, Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology 1, Oncogene 24 (2005), 5668-5675.
332. D. S. Salomon, C. Bianco and S. M. De, Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia 1, Bioessays 21 (1999), 61-70.
333. L. Strizzi, C. Bianco, N. Normanno, M. Seno, C. Wechselberger, B. Wallace-Jones, N. I. Khan, M. Hirota, Y. Sun, M. Sanicola and D. S. Salomon, Epithelial mesenchymal transitionis a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice 1, J Cell Physiol 201 (2004), 266-276.
334. C. Wechselberger, A. D. Ebert, C. Bianco, N. I. Khan, Y. Sun, B. Wallace-Jones, R. Montesano and D. S. Salomon, Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells 2, Exp Cell Res 266 (2001), 95-105.
335. N. P. Mongan, K. M. Martin and L. J. Gudas, The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures 1, Mol Carcinog 45 (2006), 887-900.
336. S. Hockfield and R. D. McKay, Identification of major cell classes in the developing mammalian nervous system 1, J Neurosci 5 (1985), 3310-3328.
337. K. Frederiksen and R. D. McKay, Proliferation and differentiation of rat neuroepithelial precursor cells in vivo 1, J Neurosci 8 (1988), 1144-1151.
338. E. Fuchs and K. Weber, Intermediate filaments: structure, dynamics, function, and disease 2, Annu Rev Biochem 63 (1994), 345-382.
339. V. A. Spencer, S. K. Samuel and J. R. Davie, Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines 1, Cancer Res 60 (2000), 288-292.
340. S. Weggen, T. A. Bayer, A. Koch, H. Salewski, K. H. Scheidtmann, T. Pietsch and O. D. Wiestler, Characterization of neural cell lines derived from SV40 large T-induced primitive neuroectodermal tumors 1, Brain Pathol 7 (1997), 731-739.
341. J. Dahlstrand, V. P. Collins and U. Lendahl, Expression of the class VI intermediate filament nestin in human central nervous system tumors 1, Cancer Res 52 (1992), 5334-5341.
342. T. Tohyama, V. M. Lee, L. B. Rorke, M. Marvin, R. D. McKay and J. Q. Trojanowski, Nestin expression inembryonic human neuroepithelium and in human neuroepithelial tumor cells 2, Lab Invest 66 (1992), 303-313.
343. N. Duggal, R. Schmidt-Kastner and A. M. Hakim, Nestin expression in reactive astrocytes following focal cerebral ischemia in rats 1, Brain Res 768 (1997), 1-9.
344. J. T. Rutka, S. Ivanchuk, S. Mondal, M. Taylor, K. Sakai, P. Dirks, P. Jun, S. Jung, L. E. Becker and C. Ackerley, Coexpression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells 1, Int J Dev Neurosci 17 (1999), 503-515.
345. V. A. Florenes, R. Holm, O. Myklebost, U. Lendahl and O. Fodstad, Expression of the neuroectodermal intermediate filament nestin in human melanomas 1, Cancer Res 54 (1994), 354-356.
346. S. K. Thomas, C. A. Messam, B. A. Spengler, J. L. Biedler and R. A. Ross, Nestin is a potential mediator of malignancy in human neuroblastoma cells 1, J Biol Chem 279 (2004), 27994-27999.
347. M. V. Lobo, M. I. Arenas, F. J. Alonso, G. Gomez, E. Bazan, C. L. Paino, E. Fernandez, B. Fraile, R. Paniagua, A. Moyano and E. Caso, Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours 1, Cell Tissue Res 316 (2004), 369-376.
348. A. Y. Maslov, T. A. Barone, R. J. Plunkett and S. C. Pruitt, Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice 1, J Neurosci 24 (2004), 1726-1733.
349. H. R. Schlesinger, L. Rorke, R. Jamieson and K. Hummeler, Neuronal properties of neuroectodermal tumors in vitro 1, Cancer Res 41 (1981), 2573-2575.
350. A. Mohan, M. Kandalam, H. L. Ramkumar, L. Gopal and S. Krishnakumar, Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma 1, Br J Ophthalmol 90 (2006), 889-893.
351. H. Okano, H. Kawahara, M. Toriya, K. Nakao, S. Shibata and T. Imai, Function f RNA-binding protein Musashi-1 in stem cells 1, Exp Cell Res 306 (2005), 349-356.
352. K. Uchida, M. Mukai, H. Okano and T. Kawase, Possible oncogenicity of subventricular zone neural stem cells: case report 1, Neurosurgery 55 (2004), 977-978.
353. S. Ladisch, F. Chang, R. Li, P. Cogen and D. Johnson, Detection of medulloblastoma and astrocytoma-associated ganglioside GD3 in cerebrospinal fluid 1, Cancer Lett 120 (1997), 71-78.
354. T. D. Traylor andE. L. Hogan, Gangliosides of human cerebral astrocytomas 1, J Neurochem 34 (1980), 126-131.
355. M. Chekenya and G. J. Pilkington, NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours 1, J Neurocytol 31 (2002), 507-521.
356. A. Schermer, S. Galvin and T. T. Sun, Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells 1, J Cell Biol 103 (1986), 49-62.
357. M. A. Kurpakus, E. L. Stock and J. C. Jones, Expression of the 55-kD/64-kD corneal keratins in ocular surface epithelium 2, Invest Ophthalmol Vis Sci 31 (1990), 448-456.
358. R. B. Clarke, K. Spence, E. Anderson, A. Howell, H. Okano andC. S. Potten, Aputative human breast stem cell population is enriched for steroid receptor-positive cells 2, Dev Biol 277 (2005), 443-456.
359. B. W. Booth and G. H. Smith, Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands 1, Breast Cancer Res 8 (2006), R49.
360. S. Nishizuka, Profiling cancer stem cells using protein array technology 1, Eur J Cancer 42 (2006), 1273-1282.
361. Y. Hu, S. Swerdlow, T. M. Duffy, R. Weinmann, F. Y. Lee and S. Li, Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice 1, Proc Natl Acad Sci U S A 103 (2006), 16870-16875.
362. T. O'Hare, A. S. Corbin and B. J. Druker, Targeted CML therapy: controlling drug resistance, seeking cure 1, Curr Opin Genet Dev 16 (2006), 92-99.
363. E. L. Sievers, Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates 1, Cancer Chemother Pharmacol 46 (2000), S18-S22.
364. C. Gridelli, P. Maione, G. F. Del, G. Colantuoni, C. Guerriero, C. Ferrara, D. Nicolella, D. Comunale, V. A. De and A. Rossi, Sorafenib and sunitinib in the treatment of advanced nonsmall cell lung cancer 1, Oncologist 12 (2007), 191-200.
365. S. Sell, Potential gene therapy strategies for cancer stem cells 1, Curr Gene Ther 6 (2006), 579-591.
366. L. J. Elrick, H. G. Jorgensen, J. C. Mountford and T. L. Holyoake, Punish the parent not the progeny 1, Blood 105 (2005), 1862-1866.
367. J. Thomas, L. Wang, R. E. Clark and M. Pirmohamed, Active transport of imatinib into and out of cells: implications for drug resistance 1, Blood 104 (2004), 3739-3745.
368. M. Diehn, R. W. Cho, N. A. Lobo, T. Kalisky, M. J. Dorie, A. N. Kulp, D. Qian, J. S. Lam, L. E. Ailles, M. Wong, B. Joshua, M. J. Kaplan, I. Wapnir, F. M. Dirbas, G. Somlo, C. Garberoglio, B. Paz, J. Shen, S. K. Lau, S. R. Quake, J. M. Brown, I. L. Weissman and M. F. Clarke, Association of reactive oxygen species levels and radioresistance in cancer stem cells, Nature 458 (2009), 780-783.
369. M. Dean, T. Fojo and S. Bates, Tumour stem cells and drug resistance, Nat. Rev. Cancer 5 (2005), 275-284.
370. M. M. Gottesman, T. Fojo and S. E. Bates, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat Rev Cancer 2 (2002), 48-58.
371. M. Dean, T. Fojo and S. Bates, Tumour stem cells and drug resistance, Nat Rev Cancer 5 (2005), 275-284.
372. S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A. B. Hjelmeland, Q. Shi, R. E. McLendon, D. D. Bigner and J. N. Rich, Stem Cell-like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor, Cancer Res 66 (2006), 7843-7848.
373. M. J. Hendrix, E. A. Seftor, A. R. Hess and R. E. Seftor, Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma, Nat Rev Cancer 3 (2003), 411-421.
374. L. Clarke and K. D. van der, Low oxygen enhances primitive and definitive neural stem cell colony formation by inhibiting distinct cell death pathways, Stem Cells 27 (2009), 1879-1886.
375. V. Moreno-Manzano, F. J. Rodriguez-Jimenez, J. L. cena- Bonilla, S. Fustero-Lardies, S. Erceg, J. Dopazo, D. Montaner, M. Stojkovic and J. M. Sanchez-Puelles, FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status, J Biol Chem 285 (2010), 1333-1342.
376. J. M. Heddleston, Z. Li, R. E. McLendon, A. B. Hjelmeland and J. N. Rich, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle 8 (2009), 3274-3284.
377. A. E. Grulich, M. T. van Leeuwen, M. O. Falster and C. M. Vajdic, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a metaanalysis, Lancet 370 (2007), 59-67.
378. M. Todaro, M. P. Alea, A. B. Di Stefano, P. Cammareri, L. Vermeulen, F. Iovino, C. Tripodo, A. Russo, G. Gulotta, J. P. Medema and G. Stassi, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell 1 (2007), 389-402.
379. J. N. Rich and S. Bao, Chemotherapy and cancer stem cells, Cell Stem Cell 1 (2007), 353-355.
380. C. E. Eyler, W. C. Foo, K. M. LaFiura, R. E. McLendon, A. B. Hjelmeland and J. N. Rich, Brain cancer stem cells display preferential sensitivity to Akt inhibition, Stem Cells 26 (2008), 3027-3036.
381. J. Tammam, C. Ware, C. Efferson, J. O'Neil, S. Rao, X. Qu, J. Gorenstein, M. Angagaw, H. Kim, C. Kenific, K. Kunii, K. J. Leach, G. Nikov, J. Zhao, X. Dai, J. Hardwick, M. Scott, C. Winter, L. Bristow, C. Elbi, J. F. Reilly, T. Look, G. Draetta, P. L. Van der, N. E. Kohl, P. R. Strack and P. K. Majumder, Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia, Br J Pharmacol 158 (2009), 1183-1195.
382. S. G. Piccirillo, B. A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco and A. L. Vescovi, Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature 444 (2006), 761-765.
383. P. Rizzo, C. Osipo, K. Foreman, T. Golde, B. Osborne and L. Miele, Rational targeting of Notch signaling in cancer, Oncogene 27 (2008), 5124-5131.
384. D. Dingli and F. Michor, Successful therapy must eradicate cancer stem cells , Stem Cells 24 (2006), 2603-2610.
385. R. E. Drasga, L. H. Einhorn, S. D. Williams, D. N. Patel and E. E. Stevens, Fertility after chemotherapy for testicular cancer 1, J Clin Oncol 1 (1983), 179-183.
386. R. Ohno, N. Asou and K. Ohnishi, Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate 1, Leukemia 17 (2003), 1454-1463.
387. M. L. Guzman, C. F. Swiderski, D. S. Howard, B. A. Grimes, R. M. Rossi, S. J. Szilvassy and C. T. Jordan, Preferential induction of apoptosis for primary human leukemic stem cells 1, Proc Natl Acad Sci U S A 99 (2002), 16220-16225.
388. K. E. Miletti-Gonzalez, S. Chen, N. Muthukumaran, G. N. Saglimbeni, X. Wu, J. Yang, K. Apolito,W. J. Shih,W. N. Hait and L. Rodriguez-Rodriguez, The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer 1, Cancer Res 65 (2005), 6660-6667.
389. C. Folkins, S. Man, P. Xu, Y. Shaked, D. J. Hicklin and R. S. Kerbel, Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors 1, Cancer Res 67 (2007), 3560-3564.
390. K. Hosokawa, F. Arai, H. Yoshihara, Y. Nakamura, Y. Gomei, H. Iwasaki, K. Miyamoto, H. Shima, K. Ito and T. Suda, Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction, Biochem Biophys Res Commun 363 (2007), 578-583.
391. C. Cobaleda, N. Gutierrez-Cianca, J. Perez-Losada, T. Flores, R. Garcia-Sanz, M. Gonzalez and I. Sanchez-Garcia, A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia, Blood 95 (2000), 1007-1013.
392. G. M. Seigel, L. M. Campbell, M. Narayan and F. Gonzalez- Fernandez, Cancer stem cell characteristics in retinoblastoma , Mol Vis 11 (2005), 729-737.
393. C. F. Kim, E. L. Jackson, A. E. Woolfenden, S. Lawrence, I. Babar, S. Vogel, D. Crowley, R. T. Bronson and T. Jacks, Identification of bronchioalveolar stem cells in normal lung and lung cancer, Cell 121 (2005), 823-835.
394. D. Fang, T. K. Nguyen, K. Leishear, R. Finko, A. N. Kulp, S. Hotz, P. A. Van Belle, X. Xu, D. E. Elder and M. Herlyn, A tumorigenic subpopulation with stem cell properties in melanomas, Cancer Res 65 (2005), 9328-9337.
395. E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A. Piccinini, D. Porro, M. Santinami, G. Invernici, E. Parati, G. Alessandri and C. A. La Porta, Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential, Eur J Cancer 43 (2007), 935-946.